MedTrace Logo

Pre-operative Aceclofenac on the Anesthetic Efficacy of IANB in Symptomatic Irreversible Pulpitis

NCT03146481 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2017-11-07

No results posted yet for this study

Summary

The aim of this randomized, double-blinded, controlled study is to evaluate the effect of pre-operative oral aceclofenac on the success of the inferior alveolar nerve block with 2% Mepivacaine containing 100,000 Epinephrine for patients with symptomatic irreversible pulpitis.

Conditions

  • Irreversible Pulpitis

Interventions

DRUG

Aceclofenac

Aceclofenac 100 mg tablet given one hour before starting the root canal treatment

OTHER

Placebo

Placebo tablet given one hour before starting the root canal treatment

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Principal Investigators

  • Nermeen A Abbas, Postgraduate · Cairo University

  • Suzan AW Amin, PhD · Cairo University

  • Shaimaa Gawdat, PhD · Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03146481 on ClinicalTrials.gov